Physical Activity in Patients With Rheumatoid Arthritis Treated With Adalimumab in Routine Clinical Practice

Study Identifier
P13-683
CT.gov Identifier
NCT01756235
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Rheumatoid Arthritis
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Had rheumatoid arthritis (RA) and is eligible to start and/or continue adalimumab therapy according to the local product label and prescription guidelines * Had been started on adalimumab therapy no more than one (1) month prior to the study enrolment * Had negative result of tuberculosis (TB) screening test or was receiving TB prophylaxis as per local guidelines * Had provided written Authorization to the investigator to use and/or disclose personal and/or health data, or Informed Consent if requested by the Local Regulations
    Exclusion Criteria:
    * Was unable to walk either due to RA or a comorbid condition * Was unable to perform basic self-care activities * Had contraindications for treatment with adalimumab

    Protocol Summary

    The purpose of this study was to evaluate physical activity and its changes in participants with rheumatoid arthritis (RA) who were treated with adalimumab therapy in clinical practice.

    Study Locations

    No locations found.